Open AccessTo evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital
Author(s) -
Vadlakonda Sruthi,
Resu Neha Reddy,
K Sowmini,
Nagur Sharone Grace
Publication year - 2020
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_174_20
Subject(s) - medicine , vernal keratoconjunctivitis , allergic conjunctivitis , ophthalmology , itching , keratoconjunctivitis , dermatology , allergy , immunology
Vernal conjunctivitis comprises 0.5% of allergic eye diseases. The study is intended to collate the effectiveness of drugs by observing the reduction in signs and symptoms.